Clinical Trial Update: Safety and Effectiveness of Blood-Brain Barrier Disruption (BBBD) in Subjects With Suspected Infiltrating Glioma [NA]

View source ↗

Summary

A clinical trial evaluating blood-brain barrier disruption for suspected infiltrating glioma sponsored by InSightec has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• ExAblate MR-guided focused ultrasound

Snippet

Sponsor: InSightec | Conditions: Glioma | NA | Status: WITHDRAWN